Catalyst Wire Dossier Catalyst Wire Dossier

CD22/CD19 CAR-T

CD22/CD19 chimeric antigen receptor T cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD22/CD19 CAR-T, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: CD22/CD19 CAR-T and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL [Phase 2]

See pricing